Krilogy Financial LLC Edwards Lifesciences Corp Transaction History

Krilogy Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 14, 2022	SELL	$86.5 - $128.27 $592,006 - $877,879	-6,844 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$101.96 - $128.34 $697,814 - $878,358	6,844 New	6,844 $806,000
Q2 2020 Aug 06, 2020	SELL	$57.54 - $76.95 $172,332 - $230,465	-2,995 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $156,967 - $242,595	2,995 New	2,995 $188,000
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $4,641 - $5,694	-100 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $4,570 - $5,803	100 New	100 $17,000
Q2 2018 Aug 15, 2018	SELL	$42.45 - $51.3 $6,367 - $7,695	-150 Closed	0 $0
Q3 2017 Nov 15, 2017	SELL	$36.29 - $38.83 $1,814 - $1,941	-50 Reduced 25.0%	150 $16,000
Q2 2017 Aug 15, 2017	BUY	N/A	200	200 $24,000

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.